CLINICAL_TRIALS
trial_result
· 2019-12-30
Clinical Trial Update: Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone [Phase 3]
Summary
Phase 3 long-term assessment trial of lubiprostone for opioid-induced bowel dysfunction has completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sucampo Pharma Americas, LLC | Conditions: Opioid-Induced Bowel Dysfunction | Phase 3 | Status: COMPLETED | Results posted: 2019-12-30